TherapeuticsMD Inc (TXMD) stock trades up, “Positive” rating reaffirmed by Jefferies Group LLC Analysts

TherapeuticsMD Inc (NASDAQ: TXMD) shares rose on Wednesday January 25 on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Meanwhile, the Dow Jones Industrial Average on Wednesday crossed the 20,000 level for the first time, while the S&P 500 and Nasdaq Composite also traded in record territory shortly after the market opened

The Dow Jones Industrial Average DJIA, +0.60% advanced 100 points, or 0.5%, to 20,012,
The S&P 500 index SPX, +0.55% gained 10 points, or 0.5%, to 2,289, with eight of the main 11 sectors trading higher.

The Nasdaq Composite index COMP, +0.66% was 30 points, or 0.6%, higher at 5,630.

All three main indexes set intraday records shortly after the opening bell.

Jefferies Group LLC analysts reiterated its Positive rating on TherapeuticsMD Inc (NASDAQ: TXMD) in a note to investors, making it one of the more closely watched stocks on Wall Street. Jefferies Group LLC currently has a rating of Positive on the shares. A number of other analysts have spoken on the stock in recent days, and the company has earned a consensus one-year price target of $19.69, above the opening price of $5.70, a difference of 34.07 percent. TherapeuticsMD Inc stock has a 52-week high of $9.29. Usually, after analysts publish a “reiterated rating” report on a stock, they will later issue other revisions, such as a price target change.

Shares of TherapeuticsMD Inc (NASDAQ: TXMD) opened at $5.70 yesterday and traded in a range between, $5.68 and $5.78, and last traded at $5.78, a jump of $0.14 over the previous closing price.

TherapeuticsMD Inc (NASDAQ: TXMD) currently has a market cap of 1.14B.

TherapeuticsMD Inc (NASDAQ: TXMD) Average Daily Trading Volume

458,821 shares traded hands yesterday, 31 percent below the norm, out of a total float 153,114,000. lower than normal. Look for trading volume to pick up in the coming days as swing traders often use increases in trading volume to identify heavy volume accumulation or distribution by institutional investors.

While increased trading for short periods will not mean much will not mean much, conversely, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.

Institutional sponsorship simply refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Institutional investors such as these retain teams of analysts researching thousands of stocks. So watching their interests is a good way to make sure you are buying the right stocks.

TherapeuticsMD Inc (NASDAQ: TXMD) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By spotting trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.

With that in mind, TherapeuticsMD Inc (NASDAQ: TXMD) now has a 50-day MA of $5.92 and 200-day MA of $6.60. It has traded in a 52-week range between $4.39 – 9.29 and today’s last price is 37.78%% lower than the 52 week high of $9.29.

Earnings growth is a critical factor to consider when investing in stocks and investors seek companies that have raised their earnings by at least 25% over a 3 year period.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply